Clinical trials: Elevated Liver Enzymes

Chronic Hepatitis C

Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C

• Completed
• Age: 18 to 65 years
• Phase 2

A Phase 2, randomized, double-blind, parallel design trial of two doses of mitoquinone mesylate (MitoQ) and of placebo in patients with chronic Hepatitis C.

Trial name

NCT00433108

Testing

Mitoquinone mesylate (MitoQ)

Where

2 sites in New Zealand

Volunteers

30 people

Sponsor

Antipodean Pharmaceuticals, Inc.